Fig. 3From: Nomogram-derived prediction of pathologic complete response (pCR) in breast cancer patients treated with neoadjuvant chemotherapy (NCT)The receiver-operating characteristics (ROC) curve for validating nomogram model. (The AUC was 0.758 (95% CI = 0.675–0.841))Back to article page